Glimmers of hope for MDR-Tuberculosis treatment
The Lancet Respiratory Medicine in conversation with
English - January 08, 2019 15:30 - 8 minutes - 5.99 MBLife Sciences Science Education lungs pulmonary smoking vape flu Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Effectiveness of flu vaccine over time
Next Episode: Lung volume reduction and emphysema
Dr Raj Gupta discusses the potential of delaminid, one of the first new TB drugs to enter the market in 40 years, to offer new hope for treatment of multi drug resistant tuberculosis.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv